(9-243) Clinical Impact of Targeting a Narrow Vancomycin AUC Range of 350–500 mg·h/L Without Adjustment for MIC in Patients with Methicillin-Resistant Staphylococcus aureus Infections
Wednesday, December 10, 2025
8:30 AM - 9:30 AM
Location: Bayside A, Level 1
Residency Program: Middlesex Hospital Residency Program Type: PGY1 (Pharmacy) Residency Program Location: Connecticut
